Tagged with Griffith Institute for Drug Discovery

Natural compounds derived from Australian plants have been found to stimulate cells that are useful for transplantation to repair spinal cord injuries.

Professor Jennifer Martin AC experienced a memorable 2017 with numerous honours, awards and accolades for her leading role in protein crystallography research, promoting women in science, and science communication. But just weeks into the new year, the Director of Griffith University’s Institute for Drug Discovery (GRIDD) has been recognised again with one of the highest […]

Griffith University research into malaria, gut infections and streptococcus are some of the projects set to benefit from National Health and Medical Research Council (NHMRC) 2018 Project Grant funding announced this week.

A Griffith University researcher says we urgently need to safeguard current antibiotics and discover new ones to avoid what has been described recently by England’s Chief Medical Officer, Prof Dame Sally Davies as a “post-antibiotic apocalypse.” Griffith Institute for Drug Discovery (GRIDD) scientist Dr Róisín McMahon has just been awarded a $150,000 Ramaciotti Health Investment […]

Professor Jennifer Martin has been honoured by HRH Prince Andrew as a Bragg Member with the Royal Institute of Australia. Prominent Australian scientists were presented with the prestigious membership by the Duke of York on Wednesday, September 20. Named after prominent Australian Pioneer scientists, Sir William Henry Bragg and Sir William Lawrence Bragg, the membership […]

When 11-year-old Emma has her mum along to netball games, little do her teammates know that her mum is working to tackle one of the world’s deadliest diseases. Professor Kathy Andrews is a leading biomedical scientist working to save millions of lives by finding new treatments for malaria, but when she leaves the Griffith Institute […]

Griffith University scientists have helped discover new compounds which could help block the transmission of the deadly disease malaria. A team of Griffith researchers has found a novel class of compounds, the hexahydro quinoline (HHQ), with potent activity against the parasite stages responsible for the clinical symptoms of malaria and its transmission to mosquitoes.